Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Light Chain Amyloidosis Clinical Trials Near Me

As of November 13, 2026, 39 Light Chain Amyloidosis clinical trials are recruiting now and 9 are not yet recruiting. In the US, 16 of them have at least 1 open site, across 27 states and Washington, DC. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Light Chain Amyloidosis pageMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+97 more

All 39 Light Chain Amyloidosis trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
    Most sites in Michigan, Wisconsin and Florida
    RecruitingPhase 3Ages 18+SWOG Cancer Research Network
    115US sites
    25 states
  2. A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
    Most sites in New York, Arizona and California
    RecruitingPhase 1/2Ages 18+Alexion Pharmaceuticals
    12US sites
    10 states
  3. A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
    Most sites in New York, North Carolina and Florida
    RecruitingPhase 1/2Ages 18+AbbVie
    12US sites
    9 states
  4. A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
    Most sites in California, New York and Colorado
    RecruitingPhase 1Ages 18+Janssen Research & Development
    9US sites
    6 states
  5. A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
    Most sites in California, Colorado and Massachusetts
    RecruitingPhase 1/2Ages 18+Regeneron Pharmaceuticals
    8US sites
    8 states
  6. Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
    Most sites in Massachusetts, Connecticut and Ohio
    RecruitingPhase 1/2Ages 18+Dana-Farber Cancer Institute
    5US sites
    3 states
  7. Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
    Most sites in Tennessee, Texas and Utah
    RecruitingPhase 1/2Ages 18+University of Texas Southwestern Medical Center
    3US sites
    3 states
  8. Teclistamab-Daratumumab in AL Amyloidosis
    Most sites in Massachusetts, New York and Wisconsin
    RecruitingPhase 2Ages 18-100Rajshekhar Chakraborty, MD
    3US sites
    3 states
  9. A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
    Most sites in Colorado and Georgia
    RecruitingPhase 1Ages 18+Janssen Research & Development
    2US sites
    2 states
  10. Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
    Most sites in Arizona and Minnesota
    RecruitingPhase 2Ages 18+Mayo Clinic
    2US sites
    2 states
  11. DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
    Only in Michigan
    RecruitingPhase 2Ages 18+Barbara Ann Karmanos Cancer Institute
    1US site
  12. Molecular Imaging of Primary Amyloid Cardiomyopathy
    Only in Massachusetts
    RecruitingAges 18-99Brigham and Women's Hospital
    1US site
  13. Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
    Only in Ohio
    RecruitingAges 18+Ohio State University Comprehensive Cancer Center
    1US site
  14. SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
    Only in Minnesota
    RecruitingAges 18+Mayo Clinic
    1US site
  15. A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis
    RecruitingAges 18-70Peking University First Hospital
    No US site yet
  16. A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
    RecruitingAges 18-99Fondazione IRCCS Policlinico San Matteo di Pavia
    No US site yet
  17. A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
    RecruitingPhase 2Ages 18+Shanghai Zhongshan Hospital
    No US site yet
  18. A Registry of AL Amyloidosis (ReAL)
    RecruitingAges 18-99Fondazione IRCCS Policlinico San Matteo di Pavia
    No US site yet
  19. Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
    RecruitingPhase 1/2Ages 18-80Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co.
    No US site yet
  20. BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
    RecruitingPhase 2Ages 18+Institute of Hematology & Blood Diseases Hospital, China
    No US site yet
Get an email when Light Chain Amyloidosis trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Light Chain Amyloidosis:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Light Chain Amyloidosis trials in the US, and what stage they are in

Of the 16 Light Chain Amyloidosis trials with a US site, 1 is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 12 of them. The remaining 3 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 5 of them, and universities, hospitals, foundations and government groups run 11. The sponsors with the most are Janssen Research & Development (2) and Mayo Clinic (2). The most recently listed one first appeared on ClinicalTrials.gov on September 30, 2026.

Light Chain Amyloidosis trials in the US, state by state

None of the 16 Light Chain Amyloidosis trials with a US site lists children under 18 as eligible. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
Massachusetts707Boston (7)
Minnesota606Rochester (6), Coon Rapids (1), Edina (1), plus 3 more
New York606New York (5), Buffalo (1), Commack (1), plus 2 more
Ohio606Cleveland (4), Columbus (3)
California505Duarte (3), Irvine (2), San Francisco (2), plus 2 more
Tennessee505Nashville (4), Collierville (1), Memphis (1)
Michigan404Detroit (4), Ann Arbor (1), Clinton Township (1), plus 7 more
Texas404Houston (3), Baytown (1), Cypress (1), plus 4 more
Arizona303Goodyear (1), Phoenix (1), Scottsdale (1), plus 1 more
Colorado303Denver (3)
Show the other 18 states
Florida303Miami (2), Aventura (1), Coral Gables (1), plus 6 more
North Carolina303Charlotte (3), Winston-Salem (2), Durham (1), plus 2 more
Wisconsin303Milwaukee (3), Green Bay (1), La Crosse (1), plus 4 more
Connecticut202New Haven (2), Derby (1), Greenwich (1), plus 5 more
Georgia202Atlanta (2)
Missouri202St Louis (2), City of Saint Peters (1), Creve Coeur (1)
Oregon202Portland (2), Newberg (1), Oregon City (1)
Pennsylvania202Philadelphia (2), Danville (1), Wilkes-Barre (1)
District of Columbia101Washington D.C. (1)
Illinois101Aurora (1), Chicago (1), Danville (1), plus 4 more
Iowa101Ankeny (1), Clive (1), Des Moines (1), plus 1 more
Kansas101Kansas City (1), Westwood (1)
Maryland101Bethesda (1)
Mississippi101Oxford (1), Southhaven (1)
Nebraska101Bellevue (1), Omaha (1)
New Jersey101Middletown (1), Montvale (1)
Utah101Salt Lake City (1)
Washington101Seattle (1)

US hospitals running the most Light Chain Amyloidosis trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Light Chain Amyloidosis.

  1. Boston Medical CenterBoston, Massachusetts3 trials
  2. Mayo Clinic in RochesterRochester, Minnesota3 trials
  3. City of HopeDuarte, California2 trials
  4. Colorado Blood Cancer InstituteDenver, Colorado2 trials
  5. Karmanos Cancer InstituteDetroit, Michigan2 trials
  6. MD Anderson Cancer CenterHouston, Texas2 trials
  7. Medical College of WisconsinMilwaukee, Wisconsin2 trials
  8. Memorial Sloan Kettering Cancer CenterNew York, New York2 trials
  9. Yale UniversityNew Haven, Connecticut2 trials
  10. Abbott-Northwestern HospitalMinneapolis, Minnesota1 trial

Help getting to a Light Chain Amyloidosis trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding a Light Chain Amyloidosis trial near you

Are there Light Chain Amyloidosis clinical trials near me?

As of November 13, 2026, 39 Light Chain Amyloidosis clinical trials are recruiting now and 9 are not yet recruiting. In the US, 16 of them have at least 1 open site, across 27 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Light Chain Amyloidosis clinical trial sites?

Recruiting Light Chain Amyloidosis trials list open sites in 27 states and Washington, DC. Massachusetts, Minnesota and New York have the most, and the table on this page lists every state.

Are there Light Chain Amyloidosis trials for children near me?

None of the 16 Light Chain Amyloidosis trials with a US site lists children under 18 as eligible. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to a Light Chain Amyloidosis clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.

What if there is no Light Chain Amyloidosis trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Light Chain Amyloidosis trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for Light Chain Amyloidosis: Darzalex Faspro (daratumumab and hyaluronidase-fihj).

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.